WO2012166585A2 - Re-calibration of ab ndir gas sensors - Google Patents
Re-calibration of ab ndir gas sensors Download PDFInfo
- Publication number
- WO2012166585A2 WO2012166585A2 PCT/US2012/039539 US2012039539W WO2012166585A2 WO 2012166585 A2 WO2012166585 A2 WO 2012166585A2 US 2012039539 W US2012039539 W US 2012039539W WO 2012166585 A2 WO2012166585 A2 WO 2012166585A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gas
- sensor
- ndir
- gas sensor
- ratio
- Prior art date
Links
- 238000011088 calibration curve Methods 0.000 claims abstract description 55
- 238000010521 absorption reaction Methods 0.000 claims abstract description 41
- 230000003595 spectral effect Effects 0.000 claims abstract description 19
- 238000001745 non-dispersive infrared spectroscopy Methods 0.000 claims abstract 27
- 238000000034 method Methods 0.000 claims description 62
- 230000007935 neutral effect Effects 0.000 claims description 7
- 238000001514 detection method Methods 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 5
- 239000007789 gas Substances 0.000 description 166
- 230000008859 change Effects 0.000 description 20
- 230000006870 function Effects 0.000 description 18
- 238000005259 measurement Methods 0.000 description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 238000005070 sampling Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000007665 sagging Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
- G01J3/42—Absorption spectrometry; Double beam spectrometry; Flicker spectrometry; Reflection spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01J—MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRARED, VISIBLE OR ULTRAVIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
- G01J3/00—Spectrometry; Spectrophotometry; Monochromators; Measuring colours
- G01J3/28—Investigating the spectrum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/27—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection ; circuits for computing concentration
- G01N21/274—Calibration, base line adjustment, drift correction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
- G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
- G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
- G01N21/3504—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing gases, e.g. multi-gas analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
- G01N21/59—Transmissivity
- G01N21/61—Non-dispersive gas analysers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/06—Illumination; Optics
- G01N2201/066—Modifiable path; multiple paths in one sample
- G01N2201/0662—Comparing measurements on two or more paths in one sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2201/00—Features of devices classified in G01N21/00
- G01N2201/12—Circuits of general importance; Signal processing
- G01N2201/127—Calibration; base line adjustment; drift compensation
- G01N2201/12746—Calibration values determination
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Mathematical Physics (AREA)
- Theoretical Computer Science (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12794011.2A EP2715291A4 (en) | 2011-05-31 | 2012-05-25 | Re-calibration of ab ndir gas sensors |
AU2012262488A AU2012262488A1 (en) | 2011-05-31 | 2012-05-25 | Re-calibration of AB NDIR gas sensors |
CA2837588A CA2837588A1 (en) | 2011-05-31 | 2012-05-25 | Re-calibration of ab ndir gas sensors |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/149,738 US8178832B1 (en) | 2011-05-31 | 2011-05-31 | Re-calibration methodology for NDIR gas sensors |
US13/149,738 | 2011-05-31 | ||
US13/348,568 US8222606B1 (en) | 2011-05-31 | 2012-01-11 | Air sampler for recalibration of absorption biased designed NDIR gas sensors |
US13/348,568 | 2012-01-11 | ||
US13/420,323 US8217355B1 (en) | 2011-05-31 | 2012-03-14 | Self-commissioning NDIR gas sensors |
US13/420,323 | 2012-03-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012166585A2 true WO2012166585A2 (en) | 2012-12-06 |
WO2012166585A3 WO2012166585A3 (en) | 2014-05-08 |
Family
ID=47260211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2012/039539 WO2012166585A2 (en) | 2011-05-31 | 2012-05-25 | Re-calibration of ab ndir gas sensors |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2715291A4 (en) |
AU (1) | AU2012262488A1 (en) |
CA (1) | CA2837588A1 (en) |
WO (1) | WO2012166585A2 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016173888A1 (en) * | 2015-04-29 | 2016-11-03 | Smartgas Mikrosensorik Gmbh | Sensor for detecting the concentration of at least one medium and method for operating such a sensor |
IT201900006920A1 (en) * | 2019-05-16 | 2020-11-16 | Ft System Srl | Method and apparatus for recognizing the presence of leaks from sealed containers |
SE2051347A1 (en) * | 2020-11-18 | 2022-05-19 | Senseair Ab | Method and device for determining a concentration of a component in a fluid |
WO2023274881A1 (en) * | 2021-07-01 | 2023-01-05 | Boehringer Ingelheim Vetmedica Gmbh | Method for calibrating an optical system |
CN117470795A (en) * | 2023-12-27 | 2024-01-30 | 成都千嘉科技股份有限公司 | Non-spectroscopic infrared gas sensor and gas testing method thereof |
US11913662B2 (en) | 2020-10-21 | 2024-02-27 | Senseair Ab | Temperature controller for a temperature control mechanism preventing condensation |
Citations (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1016978B (en) | 1955-05-16 | 1957-10-03 | Iashellia Res Ltd | Preparations for the control of plant growth |
EP0045665A1 (en) | 1980-08-06 | 1982-02-10 | Aktiebolaget Hässle | Enzyme inhibitors |
US5554728A (en) | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
US6177542B1 (en) | 1993-09-27 | 2001-01-23 | The Burnham Institute | Integrin-binding peptides |
US20010021500A1 (en) | 1996-04-10 | 2001-09-13 | Welch William J. | Correction of genetic defects using chemical chaperones |
US20020055174A1 (en) | 2000-05-26 | 2002-05-09 | Karola Rittner | Complex for transferring an anionic substance of interest into a cell |
US20020068272A1 (en) | 1997-08-29 | 2002-06-06 | David Larocca | Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
WO2002044184A2 (en) | 2000-11-30 | 2002-06-06 | The Penn State Research Foundation | Dna methyl transferase inhibitors |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
US20020132990A1 (en) | 2000-06-23 | 2002-09-19 | Huston James S. | Bioengineered vehicles for targeted nucleic acid delivery |
US20030003100A1 (en) | 2001-05-16 | 2003-01-02 | The Children's Hospital Of Philadelphia | DNA-antibody complexes to enhance gene transfer |
US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US20030077289A1 (en) | 2001-02-15 | 2003-04-24 | Rong-Fu Wang | Use of cell-penetrating peptides to generate antitumor immunity |
US20030083261A1 (en) | 2001-04-30 | 2003-05-01 | Hongtao Yu | Class of 12mer peptides that inhibit the function of the mitotic check point protein Mad2 |
US20030082143A1 (en) | 1997-08-29 | 2003-05-01 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
US20030082176A1 (en) | 2001-04-30 | 2003-05-01 | Symbiontics, Inc. | Subcellular targeting of therapeutic proteins |
US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
US20030125283A1 (en) | 2002-09-16 | 2003-07-03 | Gatenby Robert A. | Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents |
US20030148263A1 (en) | 1997-08-29 | 2003-08-07 | Selective Genetics, Inc. | Methods and compositions using genetic package display |
US20030166601A1 (en) | 1999-12-30 | 2003-09-04 | Woodle Martin C. | Novel colloid synthetic vectors for gene therapy |
US6673580B2 (en) | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
US20040005309A1 (en) | 2002-05-29 | 2004-01-08 | Symbiontics, Inc. | Targeted therapeutic proteins |
US20040219169A1 (en) | 1999-08-26 | 2004-11-04 | Bermudes David G. | Compositions and methods for delivery of an agent using attenuated Salmonella containing phage |
US6828401B2 (en) | 2003-05-07 | 2004-12-07 | Sunbio Inc. | Preparation method of peg-maleimide derivatives |
US20050038239A1 (en) | 2001-06-15 | 2005-02-17 | Ian Catchpole | Novel compositions |
US6869932B2 (en) | 1997-12-03 | 2005-03-22 | Applied Research Systems Ars Holding N.V. | Site-specific preparation of polyethlene glycol-GRF conjugates |
US20050071088A1 (en) | 2001-08-13 | 2005-03-31 | Landfield Philip W | Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment |
US20050147993A1 (en) | 2003-10-24 | 2005-07-07 | Shaharyar Khan | Methods and compositions for delivering polynucleotides |
US20050233356A1 (en) | 2004-02-03 | 2005-10-20 | Jones Joshua T | Live-cell biosensor polypeptides and methods of use |
US20050260756A1 (en) | 2003-01-28 | 2005-11-24 | Troy Carol M | Complex for facilitating delivery of dsRNA into a cell and uses thereof |
US20050281805A1 (en) | 2002-05-29 | 2005-12-22 | Symbiontics, Inc. | Targeted therapeutic proteins |
US20060014712A1 (en) | 2004-05-30 | 2006-01-19 | Cemines, Inc. | Controlled delivery of therapeutic compounds |
US20060051315A1 (en) | 2002-02-01 | 2006-03-09 | Scaria Puthupparampil V | Polymers for delivering peptides and small molecules in vivo |
US20060070133A1 (en) | 2004-07-15 | 2006-03-30 | Northwestern University | Methods and compositions for importing nucleic acids into cell nuclei |
US20060147997A1 (en) | 2004-11-30 | 2006-07-06 | Virosys Pharmaceuticals, Inc. | PenetraBodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases |
US20060147922A1 (en) | 2002-09-05 | 2006-07-06 | Colin Watts | Novel diagnostic and therapeutic methods and reagents therefor |
US20060154340A1 (en) | 2005-01-07 | 2006-07-13 | Louie Michael T | Expression of potato proteinase inhibitor II in microbial hosts |
US20060160743A1 (en) | 2004-09-07 | 2006-07-20 | Lianglin Zhang | Peptides that selectively home to heart vasculature and related conjugates and methods |
US20060210526A1 (en) | 2003-07-11 | 2006-09-21 | Brocchini Stephen J | Conjugated biological molecules and their preparation |
US20060233807A1 (en) | 2002-05-22 | 2006-10-19 | Catharina Svanborg | Novel therapies and methods of screening for therapeutic compounds |
US20060242725A1 (en) | 2005-04-25 | 2006-10-26 | United States Government As Represented By The Department Of Veterans Affairs, | Cell-specific molecule and method for importing DNA into osteoblast nuclei |
US20060257942A1 (en) | 2004-12-04 | 2006-11-16 | Waldo Geoffrey S | Protein subcellular localization assays using split fluorescent proteins |
WO2006136586A2 (en) | 2005-06-22 | 2006-12-28 | Complex Biosystems Gmbh | N, n-bis- (2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs |
US20070111270A1 (en) | 2004-08-23 | 2007-05-17 | The Johns Hopkins University | cAMP reporters and high throughput assays |
US20070111251A1 (en) | 2003-09-02 | 2007-05-17 | Rosania Gustavo R | Chemical address tags |
US20070157328A1 (en) | 1998-11-20 | 2007-07-05 | Imperial College Innovations Limited | Suppression of xenotransplant rejection |
WO2007090194A2 (en) | 2006-02-01 | 2007-08-09 | The Burnham Institute For Medical Research | Lymphatic zip codes in tumors and pre-malignant lesions |
US20070212332A1 (en) | 2005-08-11 | 2007-09-13 | Department Of Veterans Affairs | Methods for accelerating bone repair |
US20070231862A1 (en) | 1998-09-01 | 2007-10-04 | Diamond Scott L | Peptide scaffolds for transfer of molecules into eukaryotic cells |
US20070287680A1 (en) | 2004-05-10 | 2007-12-13 | University Of Utah Research Foundation | Combined Active and Passive Targeting of Biologically Active Agents |
US20070292920A1 (en) | 2000-11-29 | 2007-12-20 | Wei-Jen Lin | Neurotoxins with enhanced target specificity |
US20080014143A1 (en) | 2006-07-13 | 2008-01-17 | Erkki Ruoslahti | Methods and compositions for targeting gC1qR/p32 |
US20080234183A1 (en) | 2002-06-18 | 2008-09-25 | Mattias Hallbrink | Cell Penetrating Peptides |
US20080305119A1 (en) | 2004-10-29 | 2008-12-11 | University Of Rochester | Modified Bacteriophage Vectors and Uses Thereof |
US20080311136A1 (en) | 2005-08-05 | 2008-12-18 | Patrick Henry Beusker | Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation |
US20090031733A1 (en) | 2007-07-31 | 2009-02-05 | General Electric Company | Thermotunneling refrigeration system |
US20090087899A1 (en) | 2007-09-28 | 2009-04-02 | Mcknight Timothy E | Method and structure for extracting molecular species |
US20090092548A1 (en) | 2007-09-07 | 2009-04-09 | Katherine Ferrara | Methods And Compounds For Targeting Tissues |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
US20090176660A1 (en) | 2002-03-12 | 2009-07-09 | Seppo Yla-Herttuala | Engineered Baculoviruses and Their Use |
US20090176710A1 (en) | 2006-09-21 | 2009-07-09 | Phillipp Hadwiger | Complex for transferring an anionic substance into a cell |
US20090186802A1 (en) | 2005-12-16 | 2009-07-23 | Diatos | Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
US20090226372A1 (en) | 2008-02-21 | 2009-09-10 | Burnham Institute For Medical Research | Methods and compositions related to peptides and proteins with c-terminal elements |
US20090257951A1 (en) | 1998-08-25 | 2009-10-15 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
US20090258926A1 (en) | 2004-04-26 | 2009-10-15 | Centre National De La Recherche Scientifique | Methods and Compositions for Delivering siRNA into Mammalian Cells |
US20090280058A1 (en) | 2006-09-15 | 2009-11-12 | Troy Carol M | Delivery Of Double-Stranded RNA Into The Central Nervous System |
US20090305329A1 (en) | 2006-07-13 | 2009-12-10 | Szilak Laszlo | Intracellular targeting of molecules |
US20090317802A1 (en) | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
US20090325866A1 (en) | 2005-11-30 | 2009-12-31 | Jung Moon Kim | Non-activated wnt inhibition polypeptides and method for preparing the same |
US20100016215A1 (en) | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
US20100022466A1 (en) | 2006-01-27 | 2010-01-28 | Drazen Raucher | Thermally-targeted delivery of medicaments including doxorubicin |
US20100048487A1 (en) | 2005-10-28 | 2010-02-25 | Mitsubishi Tanabe Pharma Corporation | Novel cell penetrating peptide |
US20100061932A1 (en) | 2005-12-30 | 2010-03-11 | Evonik Roehm Gmbh | Peptides useful as cell-penetrating peptides |
US20100061942A1 (en) | 2006-03-20 | 2010-03-11 | Jiangie Ma | Compositions and Methods for Modulating Store-Operated Calcium Entry |
US20100099627A1 (en) | 2007-02-28 | 2010-04-22 | Yeda Research And Development Co. Ltd. | Nuclear targeting sequences |
US20100143454A1 (en) | 2007-03-22 | 2010-06-10 | Mclinden James | Flavivirus NS5A Proteins For the Treatment of HIV |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578762A (en) * | 1983-07-01 | 1986-03-25 | Tri-Med Inc. | Self-calibrating carbon dioxide analyzer |
CH664222A5 (en) * | 1984-11-30 | 1988-02-15 | Sprecher Energie Ag | METHOD AND APPARATUS FOR ON WAKE THE DENSITY OF A houses on gaseous MEDIUM IN A CLOSED AREA. |
US4694173A (en) * | 1985-10-09 | 1987-09-15 | Hibshman Corporation | Nondispersive gas analyzer having no moving parts |
FI100827B (en) * | 1995-03-22 | 1998-02-27 | Vaisala Oy | Method for calibrating an NDIR device and calibration device |
US5792938A (en) * | 1996-12-13 | 1998-08-11 | Panametrics, Inc. | Humidity sensor with differential thermal detection and method of sensing |
US6360582B1 (en) * | 2000-01-18 | 2002-03-26 | Texas Instruments Incorporated | Method for calibration of chemical sensor in measuring changes in chemical concentration |
US7705313B1 (en) * | 2005-10-18 | 2010-04-27 | Ric Investments, Llc | Ambient gas compensation in an optical system |
CA2758757A1 (en) * | 2009-04-14 | 2010-10-21 | Airware, Inc. | Saturation filtering ndir gas sensing methodology |
US8143581B2 (en) * | 2009-08-21 | 2012-03-27 | Jacob Y Wong | Absorption biased NDIR gas sensing methodology |
-
2012
- 2012-05-25 AU AU2012262488A patent/AU2012262488A1/en not_active Abandoned
- 2012-05-25 EP EP12794011.2A patent/EP2715291A4/en not_active Withdrawn
- 2012-05-25 CA CA2837588A patent/CA2837588A1/en not_active Abandoned
- 2012-05-25 WO PCT/US2012/039539 patent/WO2012166585A2/en active Application Filing
Patent Citations (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1016978B (en) | 1955-05-16 | 1957-10-03 | Iashellia Res Ltd | Preparations for the control of plant growth |
EP0045665A1 (en) | 1980-08-06 | 1982-02-10 | Aktiebolaget Hässle | Enzyme inhibitors |
US6552170B1 (en) | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US5554728A (en) | 1991-07-23 | 1996-09-10 | Nexstar Pharmaceuticals, Inc. | Lipid conjugates of therapeutic peptides and protease inhibitors |
US6177542B1 (en) | 1993-09-27 | 2001-01-23 | The Burnham Institute | Integrin-binding peptides |
US20010021500A1 (en) | 1996-04-10 | 2001-09-13 | Welch William J. | Correction of genetic defects using chemical chaperones |
US6576239B1 (en) | 1996-09-10 | 2003-06-10 | The Burnham Institute | Angiogenic homing molecules and conjugates derived therefrom |
US20030082143A1 (en) | 1997-08-29 | 2003-05-01 | Selective Genetics, Inc. | Receptor-mediated gene delivery using bacteriophage vectors |
US20020068272A1 (en) | 1997-08-29 | 2002-06-06 | David Larocca | Methods using genetic package display for detecting and identifying protein-protein interactions that facilitate internalization and transgene expression and cells or tissues competent for the same and methods for evolving gene delivery vectors |
US20030148263A1 (en) | 1997-08-29 | 2003-08-07 | Selective Genetics, Inc. | Methods and compositions using genetic package display |
US6869932B2 (en) | 1997-12-03 | 2005-03-22 | Applied Research Systems Ars Holding N.V. | Site-specific preparation of polyethlene glycol-GRF conjugates |
US20090257951A1 (en) | 1998-08-25 | 2009-10-15 | The Burnham Institute | NGR receptor and methods of identifying tumor homing molecules that home to angiogenic vasculature using same |
US20070231862A1 (en) | 1998-09-01 | 2007-10-04 | Diamond Scott L | Peptide scaffolds for transfer of molecules into eukaryotic cells |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
US20070157328A1 (en) | 1998-11-20 | 2007-07-05 | Imperial College Innovations Limited | Suppression of xenotransplant rejection |
US20040219169A1 (en) | 1999-08-26 | 2004-11-04 | Bermudes David G. | Compositions and methods for delivery of an agent using attenuated Salmonella containing phage |
US20030166601A1 (en) | 1999-12-30 | 2003-09-04 | Woodle Martin C. | Novel colloid synthetic vectors for gene therapy |
US6530944B2 (en) | 2000-02-08 | 2003-03-11 | Rice University | Optically-active nanoparticles for use in therapeutic and diagnostic methods |
US20020055174A1 (en) | 2000-05-26 | 2002-05-09 | Karola Rittner | Complex for transferring an anionic substance of interest into a cell |
US20020132990A1 (en) | 2000-06-23 | 2002-09-19 | Huston James S. | Bioengineered vehicles for targeted nucleic acid delivery |
US6673580B2 (en) | 2000-10-27 | 2004-01-06 | Genentech, Inc. | Identification and modification of immunodominant epitopes in polypeptides |
US20070292920A1 (en) | 2000-11-29 | 2007-12-20 | Wei-Jen Lin | Neurotoxins with enhanced target specificity |
WO2002044184A2 (en) | 2000-11-30 | 2002-06-06 | The Penn State Research Foundation | Dna methyl transferase inhibitors |
US20030077289A1 (en) | 2001-02-15 | 2003-04-24 | Rong-Fu Wang | Use of cell-penetrating peptides to generate antitumor immunity |
US20030082176A1 (en) | 2001-04-30 | 2003-05-01 | Symbiontics, Inc. | Subcellular targeting of therapeutic proteins |
US20030083261A1 (en) | 2001-04-30 | 2003-05-01 | Hongtao Yu | Class of 12mer peptides that inhibit the function of the mitotic check point protein Mad2 |
US20030003100A1 (en) | 2001-05-16 | 2003-01-02 | The Children's Hospital Of Philadelphia | DNA-antibody complexes to enhance gene transfer |
US20050038239A1 (en) | 2001-06-15 | 2005-02-17 | Ian Catchpole | Novel compositions |
US20050071088A1 (en) | 2001-08-13 | 2005-03-31 | Landfield Philip W | Gene expression profile biomarkers and therapeutic targets for brain aging and age-related cognitive impairment |
US20060051315A1 (en) | 2002-02-01 | 2006-03-09 | Scaria Puthupparampil V | Polymers for delivering peptides and small molecules in vivo |
US20090176660A1 (en) | 2002-03-12 | 2009-07-09 | Seppo Yla-Herttuala | Engineered Baculoviruses and Their Use |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
US20060233807A1 (en) | 2002-05-22 | 2006-10-19 | Catharina Svanborg | Novel therapies and methods of screening for therapeutic compounds |
US20050281805A1 (en) | 2002-05-29 | 2005-12-22 | Symbiontics, Inc. | Targeted therapeutic proteins |
US20040005309A1 (en) | 2002-05-29 | 2004-01-08 | Symbiontics, Inc. | Targeted therapeutic proteins |
US20080234183A1 (en) | 2002-06-18 | 2008-09-25 | Mattias Hallbrink | Cell Penetrating Peptides |
US20060147922A1 (en) | 2002-09-05 | 2006-07-06 | Colin Watts | Novel diagnostic and therapeutic methods and reagents therefor |
US20030125283A1 (en) | 2002-09-16 | 2003-07-03 | Gatenby Robert A. | Therapy of proliferative disorders by direct irradiation of cell nuclei with tritiated nuclear targetting agents |
US20050260756A1 (en) | 2003-01-28 | 2005-11-24 | Troy Carol M | Complex for facilitating delivery of dsRNA into a cell and uses thereof |
US6828401B2 (en) | 2003-05-07 | 2004-12-07 | Sunbio Inc. | Preparation method of peg-maleimide derivatives |
US20060210526A1 (en) | 2003-07-11 | 2006-09-21 | Brocchini Stephen J | Conjugated biological molecules and their preparation |
US20070111251A1 (en) | 2003-09-02 | 2007-05-17 | Rosania Gustavo R | Chemical address tags |
US20050147993A1 (en) | 2003-10-24 | 2005-07-07 | Shaharyar Khan | Methods and compositions for delivering polynucleotides |
US20050233356A1 (en) | 2004-02-03 | 2005-10-20 | Jones Joshua T | Live-cell biosensor polypeptides and methods of use |
US20090258926A1 (en) | 2004-04-26 | 2009-10-15 | Centre National De La Recherche Scientifique | Methods and Compositions for Delivering siRNA into Mammalian Cells |
US20070287680A1 (en) | 2004-05-10 | 2007-12-13 | University Of Utah Research Foundation | Combined Active and Passive Targeting of Biologically Active Agents |
US20060014712A1 (en) | 2004-05-30 | 2006-01-19 | Cemines, Inc. | Controlled delivery of therapeutic compounds |
US20060070133A1 (en) | 2004-07-15 | 2006-03-30 | Northwestern University | Methods and compositions for importing nucleic acids into cell nuclei |
US20070111270A1 (en) | 2004-08-23 | 2007-05-17 | The Johns Hopkins University | cAMP reporters and high throughput assays |
US20060160743A1 (en) | 2004-09-07 | 2006-07-20 | Lianglin Zhang | Peptides that selectively home to heart vasculature and related conjugates and methods |
US20080305119A1 (en) | 2004-10-29 | 2008-12-11 | University Of Rochester | Modified Bacteriophage Vectors and Uses Thereof |
US20060147997A1 (en) | 2004-11-30 | 2006-07-06 | Virosys Pharmaceuticals, Inc. | PenetraBodies: receptor-mediated targeted delivery of functionally-active human antibody fragments into cytosol for the treatment of chronic infections and diseases |
US20060257942A1 (en) | 2004-12-04 | 2006-11-16 | Waldo Geoffrey S | Protein subcellular localization assays using split fluorescent proteins |
US20060154340A1 (en) | 2005-01-07 | 2006-07-13 | Louie Michael T | Expression of potato proteinase inhibitor II in microbial hosts |
US20060242725A1 (en) | 2005-04-25 | 2006-10-26 | United States Government As Represented By The Department Of Veterans Affairs, | Cell-specific molecule and method for importing DNA into osteoblast nuclei |
WO2006136586A2 (en) | 2005-06-22 | 2006-12-28 | Complex Biosystems Gmbh | N, n-bis- (2-hydroxyethyl) glycine amide as linker in polymer conjugated prodrugs |
US20080311136A1 (en) | 2005-08-05 | 2008-12-18 | Patrick Henry Beusker | Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation |
US20070212332A1 (en) | 2005-08-11 | 2007-09-13 | Department Of Veterans Affairs | Methods for accelerating bone repair |
US20100048487A1 (en) | 2005-10-28 | 2010-02-25 | Mitsubishi Tanabe Pharma Corporation | Novel cell penetrating peptide |
US20090325866A1 (en) | 2005-11-30 | 2009-12-31 | Jung Moon Kim | Non-activated wnt inhibition polypeptides and method for preparing the same |
US20090317802A1 (en) | 2005-12-09 | 2009-12-24 | Bhatia Sangeeta N | Compositions and Methods to Monitor RNA Delivery to Cells |
US20090186802A1 (en) | 2005-12-16 | 2009-07-23 | Diatos | Cell Penetrating Peptide Conjugates for Delivering of Nucleic Acids into a Cell |
US20100061932A1 (en) | 2005-12-30 | 2010-03-11 | Evonik Roehm Gmbh | Peptides useful as cell-penetrating peptides |
US20100022466A1 (en) | 2006-01-27 | 2010-01-28 | Drazen Raucher | Thermally-targeted delivery of medicaments including doxorubicin |
WO2007090194A2 (en) | 2006-02-01 | 2007-08-09 | The Burnham Institute For Medical Research | Lymphatic zip codes in tumors and pre-malignant lesions |
US20100061942A1 (en) | 2006-03-20 | 2010-03-11 | Jiangie Ma | Compositions and Methods for Modulating Store-Operated Calcium Entry |
US20090305329A1 (en) | 2006-07-13 | 2009-12-10 | Szilak Laszlo | Intracellular targeting of molecules |
US20080014143A1 (en) | 2006-07-13 | 2008-01-17 | Erkki Ruoslahti | Methods and compositions for targeting gC1qR/p32 |
US20090280058A1 (en) | 2006-09-15 | 2009-11-12 | Troy Carol M | Delivery Of Double-Stranded RNA Into The Central Nervous System |
US20090176710A1 (en) | 2006-09-21 | 2009-07-09 | Phillipp Hadwiger | Complex for transferring an anionic substance into a cell |
US20100099627A1 (en) | 2007-02-28 | 2010-04-22 | Yeda Research And Development Co. Ltd. | Nuclear targeting sequences |
US20100143454A1 (en) | 2007-03-22 | 2010-06-10 | Mclinden James | Flavivirus NS5A Proteins For the Treatment of HIV |
US20100016215A1 (en) | 2007-06-29 | 2010-01-21 | Avi Biopharma, Inc. | Compound and method for treating myotonic dystrophy |
US20090031733A1 (en) | 2007-07-31 | 2009-02-05 | General Electric Company | Thermotunneling refrigeration system |
US20090092548A1 (en) | 2007-09-07 | 2009-04-09 | Katherine Ferrara | Methods And Compounds For Targeting Tissues |
US20090087899A1 (en) | 2007-09-28 | 2009-04-02 | Mcknight Timothy E | Method and structure for extracting molecular species |
US20090226372A1 (en) | 2008-02-21 | 2009-09-10 | Burnham Institute For Medical Research | Methods and compositions related to peptides and proteins with c-terminal elements |
Non-Patent Citations (213)
Title |
---|
"Remington's Pharmaceutical Sciences", MACK PUBLISHING CO. |
A.R. GENNARO,: "Remington: The Science and Practice of Pharmacy (19th ed.)", 1995, MACK PUBLISHING COMPANY |
ABI-HABIB RJ; LIU S; BUGGE TH; LEPPLA SH; FRANKEL AE: "A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony- stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts", BLOOD, vol. 104, 2004, pages 2143 - 8 |
ACEVEDO, LM.; BARILLAS S.; WEIS, SM.; GOTHERT, JR.; CHERESH., DA.: "Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts as a vascular permeability factor", BLOOD, vol. 111, 2008, pages 2674 - 2680 |
AKERMAN, M.E.; CHAN, W.C.W.; LAAKKONEN, P.; BHATIA, S.N.; RUOSLAHTI, E.: "Nanocrystal targeting in vivo", PROC. NATL. ACAD. SCI. USA, vol. 99, 2002, pages 12617 - 12621 |
ALLAM ET AL., CANCER RES., vol. 57, 1997, pages 2615 - 2618 |
ALLEN, J.W.; JOHNSON, R.S.; BHATIA, S.N.: "Hypoxic inhibition of 3-methylcholanthrene-induced CYP1A1 expression is independent ofHIF-lalpha", TOXICOL LETT, vol. 155, 2005, pages 151 - 159 |
ALMQUIST ET AL., J. MED. CHEM., vol. 23, 1980, pages 1392 - 1398 |
ALTIN JG; PAGLER EB: "A one-step procedure for biotinylation and chemical crosslinking of lymphocyte surface and intracellular membrane-associated molecules", ANAL BIOCHEM., vol. 224, 1995, pages 382 - 9 |
ANDREASEN, P. A.; EGELUND, R.; PETERSEN, H. H.: "The plasminogen activation system in tumor growth, invasion, and metastasis", CELL. MOL. LIFE SCI., vol. 57, 2000, pages 25 - 40 |
ARAP, W.; PASQUALINI, R.; RUOSLAHTI, E.: "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model", SCIENCE, vol. 279, 1998, pages 377 - 380 |
ARAP, W.; W. HAEDICKE; M. BERNASCONI; R. KAIN; D. RAJOTTE; S. KRAJEWSKI; H.M. ELLERBY; D.E. BREDESEN; R. PASQUALINI; E. RUOSLAHTI: "Targeting the prostate for destruction through a vascular address", PROC. NATL ACAD. SCI. USA, vol. 99, 2002, pages 1527 - 1531 |
AROLA, O. J.; SARASTE, A.; PULKKI, K.; KALLAJOKI, M.; PARVINEN, M.; VOIPIO-PULKKI, L. M.: "Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis", CANCER RES, vol. 60, 2000, pages 1789 - 1792 |
ASSA-MUNT, N.; JIA, X.; LAAKKONEN, P.; RUOSLAHTI, E.: "Solution structures and integrin binding activities of an RGD peptide with two isomers", BIOCHEMISTRY, vol. 40, 2001, pages 2373 - 2378 |
BACKHAUS, R.; ZEHE, C.; WEGEHINGEL, S.; KEHLENBACH, A.; SCHWAPPACH, B.; NICKEL, W.: "Unconventional protein secretion: membrane translocation of FGF-2 does not require protein unfolding", J. CELL SCI., vol. 117, 2004, pages 1727 - 1736 |
BAGRI, A.; TESSIER-LAVIGNE, M.; WATTS, R.J.: "Neuropilins in tumor biology", CLIN CANCER RES., vol. 15, 2009, pages 1860 - 4 |
BAILEY, P. J.; COUSINS, G.; SNOW, G. A.; WHITE, A. J.: "Boron-Containing Antibacterial Agents: Effects on Growth and Morphology of Bacteria Under Various Culture Conditions", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 17, 1980, pages 549 - 553 |
BARINAGA, M.: "Peptide-guided cancer drugs show promise in mice", SCIENCE, vol. 279, 1998, pages 323 - 324 |
BARRETT, ALAN J.; RAWLINGS, NEIL D.; WOESSNER, J. F.: "Handbook of proteolytic enzymes", 1998, ACADEMIC PRESS |
BARTLETT, DW.; SU, H.; HILDEBRANDT, IJ.; WEBER, W.A.; DAVIS, ME.: "Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging", PROC. NATL. ACAD. SCI USA., vol. 104, 2007, pages 15549 - 15554 |
BENNER, TIB TECH, vol. 12, 1994, pages 158 - 163 |
BERG ET AL., BIOCHEM. J., vol. 307, 1995, pages 313 - 326 |
BIACCHESI, S. ET AL.: "Modification of the trypsin-dependent cleavage activation site of the human metapneumovirus fusion protein to be trypsin independent does not increase replication or spread in rodents or nonhuman primates", J. VIROL., vol. 80, 2006, pages 5798 - 5806 |
BLASI F; CARMELIET P: "uPAR: a versatile signalling orchestrator", NAT REV MOL CELL BIOL., vol. 3, 2002, pages 932 - 43 |
BOLSTER ET AL., APPL. RADIAT. ISOT., no. 37, 1986, pages 1069 - 70 |
BREWIS, N.D.; PHELAN, A.; NORMAND, N.; CHOOLUN, E.; O'HARE, P.: "Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis", MOL. THER., vol. 7, 2003, pages 262 - 270 |
BROOKS, P. C.; MONTGOMERY, A. M.; ROSENFELD, M.; REISFELD, R. A.; HU, T.; KLIER, G.; CHERESH, D. A.: "Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels", CELL, vol. 79, 1994, pages 1157 - 1164 |
BROWN, D.; RUOSLAHTI, E.: "Metadherin, a cell-surface protein in breast tumors that mediates lung metastasis", CANCER CELL, vol. 5, 2004, pages 365 - 374 |
CAHILL ET AL., TIBS, vol. 14, no. 10, 1989, pages 400 - 403 |
CHAMBERS, T. J.; HAHN, C. S.; GALLER, R.; RICE, C. M.: "Flavivirus genome organization, expression, and replication", ANNU. REV. MICROBIOL., vol. 44, 1990, pages 649 - 688 |
CHATTERJEE, J.; GILON, C.; HOFFMAN, A.; KESSLER, H.: "N-Methylation of Peptides: A New Perspective in Medicinal Chemistry", ACCOUNTS CHEM. RES., vol. 41, 2008, pages 1331 - 1342 |
CHOI Y; MCCARTHY JR; WEISSLEDER R; TUNG CH: "Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy", CHEMMEDCHEM., vol. 1, 2006, pages 458 - 463 |
CHRISTIAN, S.; PILCH, J.; PORKKA, K.; LAAKKONEN, P.; RUOSLAHTI, E.: "Nucleolin expressed at the cell surface is a marker of endothelial cells in tumor blood vessels", J CELL BIOL., vol. 163, 2003, pages 871 - 878 |
COMAR ET AL., EUR. J. NUCL. MED., no. 1, 1976, pages 11 - 14 |
CUDIC; STAWIKOWSKI: "Peptidomimetics: Fmoc Solid-Phase Pseudopeptide Synthesis", METHODS IN MOLECULAR BIOLOGY, vol. 294, 2008, pages 223 - 246 |
CURNIS, F.; GASPARRI, A.; SACCHI, A.; LONGHI, R.; CORTI, A.: "Coupling tumor necrosis factor-a with ay integrin ligands improves its antineoplastic activity", CANCER RES., vol. 64, 2004, pages 565 - 571 |
DEBELA M; MAGDOLEN V; SCHECHTER N; VALACHOVA M; LOTTSPEICH F; CRAIK CS; CHOE Y; BODE W; GOETTIG P: "Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences", J BIOL CHEM., vol. 281, 2006, pages 25678 - 88 |
DERFUS, A.; CHEN A.; DAL-HEE M.; RUOSLAHTI, E.; BHATIA, S.: "Targeted Quantum Dot Conjugates for siRNA", DELIVERY BIOCONJUG CHEM., vol. 18, 2007, pages 1391 - 6 |
DEROSSI D; CHASSAING G; PROCHIANTZ A: "Trojan peptides: the penetratin system for intracellular delivery", TRENDS CELL BIOL., vol. 8, 1998, pages 84 - 7 |
DERVAN; BURLI: "Sequence-specific DNA recognition by polyamides", CURR OPIN CHEM BIOL, vol. 3, no. 6, 1999, pages 688 - 93 |
DESHAYES S.; MORRIS MC.; DIVITA G.; HEITZ F.: "Interactions of primary amphipathic cell penetrating peptides with model membranes: consequences on the mechanisms of intracellular delivery of therapeutics", CURRENT PHARMACEUTICAL DESIGN, vol. 11, 2005, pages 3629 - 38 |
DEVINE, D.V.; BRADLEY, A.J.: "The complement system in liposome clearance: can complements deposition be inhibited?", ADV DRUG DELIVERY REV, vol. 32, 1998, pages 19 - 39 |
DHARAP SS; MINKO T: "Targeted proapoptotic LHRH-BH3 peptide", PHARM RES., vol. 20, 2003, pages 889 - 96 |
DUCHARDT F.; FOTIN-MLECZEK M.; SCHWARZ H.; FISCHER R.; BROCK R.: "A comprehensive model for the cellular uptake of cationic cell-penetrating peptides", TRAFFIC, vol. 8, 2007, pages 848 - 66 |
DUCKERT ET AL.: "Prediction of proprotein convertase cleavage sites", PROTEIN ENGINEERING DESIGN AND SELECTION, vol. 17, no. 1, 2004, pages 107 - 112 |
DYKXHOORN, D. M.; PALLISER, D.; LIEBERMAN, J.: "The silent treatment: siRNAs as small molecule drugs", GENE THER., vol. 13, 2006, pages 541 - 552 |
ELANGO, N.; VARSANYI, T. M.; KOVAMEES, J.; NORRBY, E.: "The mumps virus fusion protein mRNA sequence and homology among the paramyxoviridae proteins", J. GEN. VIROL., vol. 70, 1989, pages 801 - 807 |
ELICEIRI, B. P.; CHERESH, D. A.: "Adhesion events in angiogenesis", CURR OPIN CELL BIOL, vol. 13, 2001, pages 563 - 568 |
ELLIOTT, G.; O'HARE, P.: "Intercellular trafficking and protein delivery by a herpesvirus structural protein", CELL, vol. 88, 1997, pages 223 - 233 |
ESMON, C. T.: "Cell mediated events that control blood coagulation and vascular injury", ANNU. REV. CELL. BIOL., vol. 9, 1993, pages 1 - 26 |
FENART, L.; CECCHELLI R.: "Protein transport in cerebral endothelium. In vitro transcytosis of transferrin", METH. MOL. MED., vol. 89, 2003, pages 277 - 290 |
FINGL ET AL.: "The Pharmacological Basis of Therapeutics", 1975, article "Ch. 1", pages: 1 |
FOGAL, V.; ZHANG, L.; RUOSLAHTI, E.: "Mitochondrial/ Cell surface protein p32/gClqR as a molecular target in tumor cells and tumor stroma", CANCER RES., vol. 68, 2008, pages 7210 - 7218 |
FRANKEL, A. D.; PABO, C. 0.: "Cellular uptake of the tat protein from human immunodeficiency virus", CELL, vol. 55, 1988, pages 1189 - 1193 |
FUJIKAWA ET AL.: "Activation of bovine factor X (Stuart factor): conversion of factor Xa alpha to factor Xa beta", PROC. NATL. ACAD. SCI., vol. 72, 1975, pages 3359 - 3363 |
GAMMON, S. T. ET AL.: "Quantitative Analysis of Permeation Peptide Complexes Labeled with Technetium-99m", CHIRAL AND SEQUENCE-SPECIFIC EFFECTS ON NET CELL UPTAKE BIOCONJUGATE CHEM., vol. 14, 2003, pages 368 - 376 |
GEIER, M.R.; TRIGG, M.E.; MERRIL, C.R.: "Fate of bacteriophage lambda in non- immune germ-free mice", NATURE, vol. 246, 1973, pages 221 - 223 |
GERETTI, E.; SHIMIZU, A.; KLAGSBRUN, M.: "Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis", ANGIOGENESIS, vol. 11, 2008, pages 31 - 39 |
GHEBREHIWET, B.; JESTY, J.; PEERSCHKE, E. I.: "gClq-R/p33: structure-function predictions from the crystal structure", IMMUNOBIOLOGY, vol. 205, 2002, pages 421 - 432 |
GONZALEZ-REYES, L. ET AL.: "Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion", PROC. NATL. ACAD. SCI. U S A, vol. 98, 2001, pages 9859 - 9864 |
GOODMAN; RO: "Burger's Medicinal Chemistry and Drug Discovery", vol. 1, 1995, JOHN WILEY & SONS, article "Peptidomimetics for Drug Design", pages: 803 - 861 |
GORDON, V. M. ET AL.: "Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases", INFECT. IMMUN., vol. 63, 1995, pages 82 - 87 |
GREEN, M.; LOEWENSTEIN, P. M.: "Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein", CELL, vol. 55, 1988, pages 1179 - 1188 |
GROZIAK, M. P.: "Boron Therapeutics on the horizon", AMERICAN JOURNAL OF THERAPEUTICS, vol. 8, 2001, pages 321 - 328 |
GUMP JM.; DOWDY SF.: "TAT transduction: the molecular mechanism and therapeutic prospects", TRENDS MOLEC. MED., vol. 13, 2007, pages 443 - 448 |
HAGEDORN; BIKFALVI, CRIT. REV. ONCOL. HEMATOL., vol. 34, 2000, pages 89 - 110 |
HAMBLEY, T.W.; HAIT, W.N.: "Is Anticancer Drug Development Heading in the Right Direction?", CANCER RES., vol. 69, 2009, pages 1259 - 1262 |
HAMZAH J.; NELSON D.; MOLDENHAUER G.; ARNOLD B.; HAMMERLING G.; GANSS R.: "Vascular Targeting of Anti-CD40/IL2 into Autochthonous Tumors Enhances Immunotherapy", J. CLIN. INVEST., vol. 118, 2008, pages 1691 - 1699 |
HANN, J. CHEM. SOC PERKIN TRANS., vol. I, 1982, pages 307 - 314 |
HANSEN M; WIND T; BLOUSE GE; CHRISTENSEN A; PETERSEN HH; KJELGAARD S; MATHIASEN L; HOLTET TL; ANDREASEN PA: "A urokinase-type plasminogen activator- inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition", J BIOL CHEM., vol. 280, 2005, pages 38424 - 37 |
HELDIN, C. H.; RUBIN, K.; PIETRAS, K.; OSTMAN, A.: "High interstitial fluid pressure - an obstacle in cancer therapy", NAT REV CANCER, vol. 4, 2004, pages 806 - 813 |
HEZEL, A. F.; KIMMELMAN, A. C.; STANGER, B. Z.; BARDEESY, N.; DEPINHO, R. A.: "Genetics and biology of pancreatic ductal adenocarcinoma", GENES DEV, vol. 20, 2006, pages 1218 - 1249 |
HOFFMAN, J.A.; GIRAUDO E.; SINGH, M.; INOUE, M.; PORKKA, K.; HANAHAN'D.; RUOSLAHTI' E.: "Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma", CANCER CELL, vol. 4, 2003, pages 383 - 391 |
HOFFMAN, J.A.; LAAKKONEN, P.; PORKKA, K.; BERNASCONI, M.; RUOSLAHTI, E.: "Phage Display: A Practical Approach", 2004, OXFORD UNIVERSITY PRESS, article "In vivo and ex vivo selections using phage-displayed libraries", pages: 171 |
HOLLADAY ET AL., TETRAHEDRON. LETT, vol. 24, 1983, pages 4401 - 4404 |
HOOD, J.D.; BEDNARSKI, M.; FRAUSTO, R.; GUCCIONE, S.; REISFELD, R.A.; XIANG, R.; CHERESH, D.A.: "Tumor regression by targeted gene delivery to the neovasculature", SCIENCE, vol. 296, 2002, pages 2404 - 2407 |
HOOK: "Proteolytic and cellular mechanisms in prohormone and proprotein processing", 1998, RG LANDES COMPANY |
HOOPER ET AL., BIOCHEM. J., vol. 321, 1997, pages 265 - 279 |
HRUBY, LIFE SCI, vol. 31, 1982, pages 189 - 199 |
HUDSON, D. ET AL., INT J PEPT PROT RES, vol. 14, 1979, pages 177 - 185 |
IBBA, BIOTECHNOLOGY & GENETIC ENGINEERING REVIEWS, vol. 13, 1995, pages 197 - 216 |
IBBA; HENNECKE, BIO/TECHNOLOGY, vol. 12, 1994, pages 678 - 682 |
JAIN R K.: "Vascular and interstitial barriers to delivery of therapeutic agents in tumors", CANCER METASTASIS REV, vol. 9, 1990, pages 253 - 266 |
JAIN R K.; TONG, R.T.; MUNN, L.L.: "Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model", CANCER RES., vol. 67, 2007, pages 2729 - 2735 |
JAIN, RK.: "Normalization of tumor vasculature: An emerging concept in anti- angiogenic therapy", SCIENCE, vol. 307, 2005, pages 58 - 62 |
JARVINEN T.; RUOSLAHTI E.: "Molecular changes in the vasculature of injured tissues", AM. J. PATH., vol. 171, 2007, pages 702 - 711 |
JENNINGS-WHITE ET AL., TETRAHEDRON LETT, vol. 23, 1982, pages 2533 |
JIA ET AL.: "Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling", J. BIOL. CHEM., vol. 281, 2006, pages 13493 - 13502 |
JIA, H. ET AL.: "Cysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosis", BIOCHEM. BIOPHYS. RES. COMMUN., vol. 283, 2001, pages 469 - 479 |
JIANG, T.; OLSON, E.S.; NGUYEN, Q.T.; ROY, M.; JENNINGS, P.A.; TSIEN, R.Y.: "Tumor imaging by means of proteolytic activation of cell-penetrating peptides", PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 17867 - 17872 |
JOHANNSEN, E. ET AL.: "Proteins of purified Epstein-Barr virus", PROC. NATL. ACAD. SCI. USA, vol. 101, 2004, pages 16286 - 16291 |
JOHNSTONE; THORPE: "Immunochemistry In Practice", 1987, BLACKWELL SCIENTIFIC PUBLICATIONS, pages: 30 - 85 |
JOLIOT, A.; PERNELLE, C.: "Deagostini-Bazin, H., and Prochiantz, A., Antennapedia homeobox peptide regulates neural morphogenesis", PROC. NATL. ACAD. SCI. U S A, vol. 88, 1991, pages 1864 - 1868 |
JOYCE, J.A.; LAAKKONEN P.; BERNASCONI, M.; BERGERS, G.; RUOSLAHTI, E.; HANAHAN, D.: "Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis", CANCER CELL, vol. 4, 2003, pages 393 - 403 |
KARMALI, P. P.; KOTAMRAJU, V. R.; KASTANTIN, M.; BLACK, M.; MISSIRLIS, D.; TIRRELL, M.; RUOSLAHTI, E.: "Targeting of albumin-embedded paclitaxel nanoparticles to tumors", NANOMEDICINE, vol. 5, 2009, pages 73 - 82 |
KE, S. H. ET AL.: "Optimal subsite occupancy and design of a selective inhibitor of urokinase", J. BIOL. CHEM., vol. 272, 1997, pages 20456 - 20462 |
KEEN ET AL., J. CEREB. BLOOD FLOW METAB., no. 9, 1989, pages 429 - 45 |
KEIL: "Specificity of Proteolysis", 1992, SPRINGER-VERLAG |
KELLY KA.; NAHRENDORFM.; YU AM.; REYNOLDS F.; WEISSLEDER R.: "In vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging", MOLECULAR IMAGING & BIOLOGY, vol. 8, no. 4, 2006, pages 201 - 207 |
KERBEL, R.S.; B.A. KAMEN: "The anti-angiogenic basis of metronomic chemotherapy", NAT REV CANCER, vol. 4, 2004, pages 423 - 436 |
KIRPOTIN, D.B. ET AL.: "Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models", CANCER RES., vol. 66, 2006, pages 6732 - 6740 |
KIRSCH ET AL., J. NEUROONCOL., vol. 50, 2000, pages 149 - 163 |
KLENK HD; GARTEN W.: "Host cell proteases controlling virus pathogenicity", TRENDS MICROBIOL., vol. 2, 1994, pages 39 - 43 |
KOEHLER, K. A.; HESS, G. P.: "New, specific and reversible bifunctional alkylborinic acid inhibitor of acetylcholinesterase", BIOCHEMISTRY, vol. 13, 1974, pages 5345 - 50 |
KOIVUNEN, E.; GAY, D. A.; RUOSLAHTI, E.: "Selection of peptides binding to the alpha 5 beta 1 integrin from phage display library", J BIOL CHEM, vol. 268, 1993, pages 20205 - 20210 |
KOIVUNEN, E.; WANG, B.; RUOSLAHTI, E.: "Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins", BIOTECHNOLOGY (N Y, vol. 13, 1995, pages 265 - 270 |
KREITMAN; PASTAN, BLOOD, vol. 90, 1997, pages 252 - 259 |
KRUITHOF EK.: "Plasminogen activator inhibitors--a review", ENZYME, vol. 40, 1988, pages 113 - 21 |
KUMAR P; WU H; MCBRIDE JL; JUNG KE; KIM MH; DAVIDSON BL; LEE SK; SHANKAR P; MANJUNATH N: "Transvascular delivery of small interfering RNA to the central nervous system", NATURE, vol. 448, 2007, pages 39 - 43 |
LAAKKONEN, P.; AKERMAN, M.E.; BILIRAN, H.; YANG, M.; FERRER, F.; KARPANEN, T.; HOFFMAN, R.M.; RUOSLAHTI, E.: "Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells", PROC. NATL. ACAD. SCI. USA., vol. 101, 2004, pages 9381 - 9386 |
LAAKKONEN, P.; PORKKA, K.; HOFFMAN, J. A.; RUOSLAHTI, E.: "A tumor-homing peptide with a targeting specificity related to lymphatic vessels", NATURE MED., vol. 8, 2002, pages 751 - 755 |
LAAKKONEN, P.; PORKKA, K.; HOFFMAN, J.A.; RUOSLAHTI, E.: "A tumor-homing peptide with a lymphatic vessel-related targeting specificity", NATURE MED, vol. 8, 2002, pages 743 - 751 |
LANGEL, UIO: "Handbook of cell-penetrating peptides, 2nd ed.", 2007, CRC/TAYLOR & FRANCIS |
LI, H.; SUN, H.; QIAN, Z.M.: "The role of the transferrin-transferrin-receptor system in drug delivery and targeting", TRENDS PHARMACOL. SCI., vol. 23, 2002, pages 206 - 209 |
LI, S-D.; HUANG, L., ANN N.Y. ACAD. SCI., vol. 1082, 2006, pages 1 - 8 |
LIU S; BUGGE TH; LEPPLA SH: "Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin", J BIOL CHEM., vol. 276, 2001, pages 17976 - 84 |
LIU, C.; HUANG, H.; DONATE, F.; DICKINSON, C.; SANTUCCI, R.; SHEIKH, A.; VESSELLA, R.; EDGINGTON, T.S.: "Prostate-specific Membrane Antigen Directed Selective Thrombotic Infarction of Tumors", CANCER RES., vol. 62, 2002, pages 5470 - 5475 |
LIU, Z. ET AL.: "In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice", NAT. NANOTECH., vol. 2, 2007, pages 47 - 52 |
MAE M.; LANGEL U.: "Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery", CURRENT OPINION IN PHARMACOLOGY, vol. 6, 2006, pages 509 - 514 |
MAEDA, H.; FANG, J.; INUTSUKA, T.; KITAMOTO, Y.: "Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications", INT IMMUNOPHARMACOL, vol. 3, 2003, pages 319 - 328 |
MARTIN ET AL., CANCER RES., vol. 60, 2000, pages 3218 - 3224 |
MAYER, L. D.; DOUGHERTY, G.; HARASYM, T. O.; BALLY, M. B.: "The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors", J PHARMACOL EXP THER, vol. 280, 1997, pages 1406 - 1414 |
MCCARTHY JR.; KELLY KA.; SUN EY.; WEISSLEDER R.: "Targeted delivery of multifunctional magnetic nanoparticles", NANOMEDICINE, vol. 2, 2007, pages 153 - 167 |
MEADE BR.; DOWDY SF.: "Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides", ADVANCED DRUG DELIVERY REVIEWS, vol. 59, no. 2-3, 2007, pages 134 - 40 |
MEDAROVA Z; PHAM W; FARRAR C; PETKOVA V; MOORE A: "In vivo imaging of siRNA delivery and silencing in tumors", NAT MED., vol. 13, 2007, pages 372 - 7 |
MERRIL, C.R.; BISWAS, B.; CARLTON, R.; JENSEN, N.C.; CREED, G.J.; ZULLO, S.; ADHYA, S.: "Long-circulating bacteriophage as antibacterial agents", PROC. NATL. ACAD. SCI. USA, vol. 93, 1996, pages 3188 - 3192 |
MILES, A. A.; MILES, E. M.: "Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs", J PHYSIOL, vol. 118, 1952, pages 228 - 257 |
MINCHINTON, A. I.; TANNOCK, I. F.: "Drug penetration in solid tumours", NAT REV CANCER, vol. 6, 2006, pages 583 - 592 |
MOGHIMI, S. M.; HUNTER, A. C.; MURRAY, J. C.: "Long-circulating and target- specific nanoparticles: Theory to practice", PHARM. REV., vol. 53, 2001, pages 283 - 318 |
MONSKY, W. L.; FUKUMURA, D.; GOHONGI, T.; ANCUKIEWCZ, M.; WEICH, H. A.; TORCHILIN, V. P.; YUAN, F.; JAIN, R. K.: "Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor", CANCER RES, vol. 59, 1999, pages 4129 - 4135 |
MORLEY, TRENDS PHARM SCI, 1980, pages 463 - 468 |
MOULARD, M.; DECROLY, E.: "Maturation of HIV envelope glycoprotein precursors by cellular endoproteases", BIOCHIM. BIOPHYS. ACTA, vol. 1469, 2000, pages 121 - 132 |
MURAKAMI; ETLINGER, BIOCHEM. BIOPHYS. RES. COMM., vol. 146, 1987, pages 1249 - 1259 |
MUROHARA, T.; HOROWITZ, J. R.; SILVER, M.; TSURUMI, Y.; CHEN, D.; SULLIVAN, A.; ISNER, J. M.: "Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin", CIRCULATION, vol. 97, 1998, pages 99 - 107 |
MURPHY, E. A.; MAJETI, B. K.; BARNES, L. A.; MAKALE, M.; WEIS, S. M.; LUTU-FUGA, K.; WRASIDLO, W.; CHERESH, D. A.: "Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis", PROC NATL ACAD SCI USA, vol. 105, 2008, pages 9343 - 9348 |
NEWTON JR.; KELLY KA.; MAHMOOD U.; WEISSLEDER R.; DEUTSCHER SL.: "In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice", NEOPLASIA (NEW YORK, vol. 8, 2006, pages 772 - 780 |
NYBERG P; YLIPALOSAARI M; SORSA T; SALO T: "Trypsins and their role in carcinoma growth", EXP CELL RES., vol. 312, 2006, pages 1219 - 28 |
OSBORNE; CORONADO-HEINSOHN, CANCER J. SCI. AM., vol. 2, 1996, pages 175 |
PAKALNS. T.; HAVERSTICK, K.L.; FIELDS, G.B.; MCCARTHY, J.B.; MOORADIAN, D.L.; TIRRELL, M.: "Cellular recognition of synthetic peptide amphiphiles in self-assembled monolayer films", BIOMATERIALS, vol. 20, 1999, pages 2265 - 2279 |
PALMACCI, S.; JOSEPHSON, L., ADVANCED MAGNETICS, 1993 |
PARK, J. H.; VON MALTZAHN, G.; ZHANG, L.; DERFUS, A. M.; SIMBERG, D.; HARRIS, T. J.; RUOSLAHTI, E.; BHATIA, S. N.; SAILOR, M. J.: "Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting", SMALL, vol. 5, 2009, pages 694 - 700 |
PARK, J-H.; V MALTZAHN G.A.; ZHANG, L.; SCHWARTZ, M.P.; RUOSLAHTI, E.; BHATIA, S.N.; SAILOR, M.J.: "Magnetic iron oxide nanoworms for tumor targeting and imaging", ADV. MATER., vol. 20, 2008, pages 1630 - 1635 |
PARR, M. J.; MASIN, D.; CULLIS, P. R.; BALLY, M. B.: "Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol", J PHARMACOL EXP THER, vol. 280, 1997, pages 1319 - 1327 |
PASQUALINI R.; KOIVUNEN E.; RUOSLAHTI E.: "Alpha v integrins as receptors for tumor targeting by circulating ligands", NAT. BIOTECH., vol. 15, 1997, pages 542 - 546 |
PASQUALINI, R.; RUOSLAHTI, E.: "Organ targeting in vivo using phage display peptide libraries", NATURE, vol. 380, 1996, pages 364 - 366 |
PIERSCHBACHER; RUOSLAHTI, E.: "Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule", NATURE, vol. 309, 1984, pages 30 - 33 |
PILCH J; BROWN DM; KOMATSU M; JARVINEN TA; YANG M; PETERS D; HOFFMAN RM; RUOSLAHTI E: "Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds", PROC NATL ACAD SCI USA., vol. 103, 2006, pages 2800 - 4 |
PIROLLO KF; RAIT A; ZHOU Q; HWANG SH; DAGATA JA; ZON G; HOGREFE RI; PALCHIK G; CHANG EH: "Materializing the potential of small interfering RNA via a tumor- targeting nanodelivery system", CANCER RES., vol. 67, 2007, pages 2938 - 43 |
POLYAKOV, V. ET AL.: "Novel Tat-Peptide Chelates for Direct Transduction of Technetium-99m and Rhenium into Human Cells for Imaging and Radiotherapy", BIOCONJUGATE CHEM., vol. 11, 2000, pages 762 - 771 |
POON GM; GARIEPY J: "Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells", BIOCHEM SOC TRANS., vol. 35, 2007, pages 788 - 93 |
PORKKA, K.; LAAKKONEN, P.; HOFFMAN, J.A.; BERNASCONI, M.; RUOSLAHTI, E.: "Targeting of peptides to the nuclei of tumor cells and tumor endothelial cells in vivo", PROC. NATL. ACAD. SCI. USA., vol. 99, 2002, pages 7444 - 7449 |
PUENTE XS; SANCHEZ LM; OVERALL CM; LOPEZ-OTIN C: "Human and mouse proteases: a comparative genomic approach", NAT REV GENET., vol. 4, 2003, pages 544 - 58 |
RAJOTTE, D.; RUOSLAHTI, E.: "Membrane dipeptidase is the receptor for a lung-targeting peptide identified by in vivo phage display", J. BIOL. CHEM., vol. 274, 1999, pages 11593 - 11598 |
REYNOLDS, A.R.; HART, I.R. ET AL.: "Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors", NAT. MED., 22 March 2009 (2009-03-22) |
RIJKEN DC.: "Plasminogen activators and plasminogen activator inhibitors: biochemical aspects", BAILLIERES CLIN HAEMATOL., vol. 8, 1995, pages 291 - 312 |
RIZO; GIERASCH, ANN. REV. BIOCHEM., vol. 61, 1992, pages 387 |
RUBINSTEIN, D. B.; STORTCHEVOI, A.; BOOSALIS, M.; ASHFAQ, R.; GHEBREHIWET, B.; PEERSCHKE, E. I.; CALVO, F.; GUILLAUME, T.: "Receptor for the globular heads of Clq (gClq-R, p33, hyaluronan-binding protein) is preferentially expressed by adenocarcinoma cells", INT J CANCER, vol. 110, 2004, pages 741 - 750 |
RUIZ-LINARES, A. ET AL.: "Processing of yellow fever virus polyprotein: role of cellular proteases in maturation of the structural proteins", J. VIROL., vol. 63, 1989, pages 4199 - 4209 |
RUOSLAHTI, E.: "Specialization of tumour vasculature", NAT. REV. CANCER, vol. 2, 2002, pages 83 - 90 |
RUOSLAHTI, E.: "Vascular zip codes in angiogenesis and metastasis", BIOCHEM. SOC. TRANSACT., vol. 32, 2004, pages 397 - 402 |
RUOSLAHTI, E.; RAJOTTE, D.: "An address system in the vasculature of normal tissues and tumors", ANNU. REV. IMMUNOL., vol. 18, 2000, pages 813 - 827 |
SANCHEZ, A. J.; VINCENT, M. J.; ERICKSON, B. R.; NICHOL, S. T.: "Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein", J. VIROL., vol. 80, 2006, pages 514 - 525 |
SANDGREN, S.; CHENG, F.; BELTING, M.: "Nuclear targeting of macromolecular polyanions by an HIV-Tat derived peptide. Role for cell-surface proteoglycans", J. BIOL. CHEM., vol. 277, 2002, pages 38877 - 38883 |
See also references of EP2715291A4 |
SIMBERG, D.; DUZA T.; PARK, J.H.; ESSLER M.; PILCH, J.; ZHANG, L.; DERFUS A.M.; YANG M.; HOFFMAN R.M.; BHATIA,S.: "Biomimetic amplification of nanoparticle homing to tumors", PROC. NATL. ACAD. SCI. USA, vol. 104, 2007, pages 932 - 936 |
SIMPELKAMP, J.; JONES, J. B.: "Borinic acid inhibitors as probes of the factors involved in binding at the active sites of subtilisin Carlsberg and .alpha.-chymotrypsin", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 2, no. 11, 1992, pages 1391 - 4 |
SJOBERG, M.; WALLIN, M.; LINDQVIST, B.; GAROFF, H.: "Furin cleavage potentiates the membrane fusion-controlling intersubunit disulfide bond isomerization activity of leukemia virus", ENV. J. VIROL., vol. 80, 2006, pages 5540 - 5551 |
SMYTH; TRAPANI, IMMUNOLOGY TODAY, vol. 16, 1995, pages 202 - 206 |
SOKER, S. ET AL.: "Neuropilin-1 is expressed by endothelial and tumor cells as an isoform- specific receptor for vascular endothelial growth factor", CELL, vol. 92, 1998, pages 735 - 745 |
SOKOLOFF, A.V.; BOCK, I.; ZHANG, G.; SEBESTYEN, M.G.; WOLFF, J.A.: "The interactions of peptides with the innate immune system studied with use of T7 phage peptide display", MOL. THER., vol. 2, 2000, pages 131 - 139 |
SOKOLOFF, A.V.; WONG, S.C.; LUDTKE, J.J.; SEBESTYEN, M.G.; SUBBOTIN, V.M.; ZHANG, G.; BUDKER, T.; BACHHUBER, M.; SUMITA, Y.; WOLFF: "A new peptide ligand that targets particles and heterologous proteins to hepatocytes in vivo", MOL. THER., vol. 8, 2003, pages 867 - 872 |
SPATOLA ET AL., LIFE SCI, vol. 38, 1986, pages 1243 - 1249 |
SPATOLA, A. F.: "Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins", 1983, MARCEL DEKKER, pages: 267 |
SPATOLA, A. F.: "Peptide Backbone Modifications", VEGA DATA, vol. 1, no. 3, March 1983 (1983-03-01) |
SPIRIDON, C. I.; GHETIE, M. A.; UHR, J.; MARCHES, R.; LI, J. L.; SHEN, G. L.; VITETTA, E. S.: "Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo", CLIN CANCER RES, vol. 8, 2002, pages 1720 - 1730 |
STARZEC, A.; VASSY, R.; MARTIN, A.; LECOUVEY, M.; DI BENEDETTO, M.; CREPIN, M.; PERRET, GY.: "Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1", LIFE SCI, vol. 79, 2006, pages 2370 - 2381 |
STEINHAUER, D. A.: "Role of hemagglutinin cleavage for the pathogenicity of influenza virus", VIROLOGY, vol. 258, 1999, pages 1 - 20 |
STERNLICHT, M. D.; WERB, Z.: "How matrix metalloproteinases regulate cell behavior", ANNU. REV. CELL. DEV. BIOL., vol. 17, 2001, pages 463 - 513 |
SUGAHARA KN; TEESALU T; KARMALI PP; KOTAMRAJU VR; AGEMY L; GREENWALD DR; RUOSLAHTI E: "Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs", SCIENCE, vol. 328, 2010, pages 1031 - 5 |
SUGAHARA, K. N.; TEESALU, T.; KARMALI, P. P.; KOTAMRAJU, V. R.; AGEMY, L.; GIRARD, O. M.; HANAHAN, D.; MATTREY, R. F.; RUOSLAHTI,: "Tissue-penetrating delivery of compounds and nanoparticles into tumors", CANCER CELL, vol. 16, no. 6, 2009, pages 510 - 20 |
TALANIAN ET AL., J. BIOL. CHEM., vol. 272, 1997, pages 9677 - 9682 |
TEESALU, T.; SUGAHARA, K. N.; KOTAMRAJU, V. R.; RUOSLAHTI, E.: "C-end rule peptides mediate neuropilin-l-dependent cell, vascular, and tissue penetration", PNAS, vol. 106, no. 38, 2009, pages 16157 - 16162 |
THOMAS, G.: "Furin at the cutting edge: from protein traffic to embryogenesis and disease", NATURE REV. MOL. CELL. BIOL., vol. 3, 2002, pages 753 - 766 |
THORNBERRY ET AL., J. BIOL. CHEM., vol. 272, 1997, pages 17907 - 17911 |
THORSON ET AL., METHODS IN MOLEC. BIOL., vol. 77, 1991, pages 43 - 73 |
THURBER, G. M.; SCHMIDT, M. M.; WITTRUP, K. D.: "Antibody tumor penetration: transport opposed by systemic and antigen-mediated clearance", ADV DRUG DELIV REV, vol. 60, 2008, pages 1421 - 1434 |
TKACHENKO ET AL., J AM CHEM SOC, vol. 125, 2003, pages 4700 - 4701 |
TORGERSEN, M. L.; SKRETTING, G.; VAN DEURS, B.; SANDVIG, K.; INTERNALIZATION OF CHOLERA TOXIN BY DIFFERENT ENDOCYTIC MECHANISMS, J. CELL. SCI., vol. 114, 2001, pages 3737 - 3747 |
TUCKER, G. C.: "Alpha v integrin inhibitors and cancer therapy", CURR OPIN INVESTIG DRUGS, vol. 4, 2003, pages 722 - 731 |
TYAGI, M.; RUSNATI, M.; PRESTA, M.; GIACCA, M.: "Internalization of HIV- tat requires cell surface heparan sulfate proteoglycans", J. BIOL. CHEM., vol. 276, 2001, pages 3254 - 3261 |
UHLAND, K.: "Matriptase and its putative role in cancer", CELL. MOL. LIFE SCI., vol. 63, 2006, pages 2968 - 2978 |
UPRICHARD, S. L.: "The therapeutic potential of RNA interference", FEBS LETT., vol. 579, 2005, pages 5996 - 6007 |
VANDER KOOI, C. W. ET AL.: "Structural basis for ligand and heparin binding to neuropilin B domains", PROC. NATL. ACAD. SCI. USA, vol. 104, 2007, pages 6152 - 6157 |
VARSANYI, T. M.; JORNVALL, H.; NORRBY, E.: "Isolation and characterization of the measles virus Fl polypeptide: comparison with other paramyxovirus fusion proteins", VIROLOGY, vol. 147, 1985, pages 110 - 117 |
VEY, M. ET AL.: "Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin", VIROLOGY, vol. 206, 1995, pages 746 - 749 |
VON WRONSKI, M. A.; RAJU, N.; PILLAI, R. ET AL.: "Tuftsin binds neuropilin-1 through a sequence similar to that encoded by exon 8 of vascular endothelial growth factor", J BIOL CHEM, vol. 281, 2006, pages 5702 - 5710 |
WADIA, J.S.; DOWDY, S.F.: "Protein transduction technology", CURR. OPIN. BIOTECH., vol. 13, 2002, pages 52 - 56 |
WAISMAN, DAVID MORTON: "Plasminogen : structure, activation, and regulation", 2003, KLUWER ACADEMIC/PLENUM |
WEINAND, A.; EHRHARDT, C.; METTERNICH, R.; TAPPARELLI, C.: "Design, Synthesis and Biological Evaluation of Selective Boron-containing Thrombin Inhibitors", BIOORGANIC AND MEDICINAL CHEMISTRY, vol. 7, 1999, pages 1295 - 1307 |
WEISSLEDER, R.; BOGDANOV, A.; NEUWELT, E. A.; PAPISOV, M.: "Long-circulating iron oxide for MR imaging", ADV. DRUG DELIV. REV., vol. 16, 1995, pages 321 - 334 |
WEISSLEDER, R.; KELLY, K.; SUN, E.Y.; SHTATLAND, T.; JOSEPHSON, L.: "Cell-specific targeting of nanoparticles by multivalent attachment of small molecules", NAT. BIOTECHNOL., vol. 23, 2005, pages 1418 - 1423 |
WEMMER; DERVAN: "Targeting the minor groove of DNA", CURR OPIN STRUCT BIOL, vol. 7, no. 3, 1997, pages 355 - 61 |
WERB, CELL, vol. 91, 1997, pages 439 - 442 |
WIESEL ET AL., J. NUCL. MED., no. 32, 1991, pages 2041 - 49 |
WOLFSBERG ET AL., J. CELL BIOL., vol. 131, 1995, pages 275 - 278 |
WOOL-LEWIS, R. J.; BATES, P.: "Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function", J. VIROL., vol. 73, 1999, pages 1419 - 1426 |
YAMAMOTO, Y.: "Molecular Design and Synthesis of B-10 Carriers for Neutron Capture Therapy", PURE APPL. CHEM., vol. 63, 1991, pages 423 - 426 |
YUAN, F.; LEUNIG, M.; HUANG, S. K.; BERK, D. A.; PAPAHADJOPOULOS, D.; JAIN, R. K.: "Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft", CANCER RES, vol. 54, 1994, pages 3352 - 3356 |
ZHANG, H.; JIRO KUSUNOSE, J.; KHEIROLOMOOM, A.; SEO, J.W.; QI, J.; WATSON, K.D.; LINDFORS, H.A.; RUOSLAHTI, E.; JULIE L.; SUTCLIFF: "Dynamic imaging of arginine-rich heart-targeted vehicles in a mouse model", BIOMATERIALS, vol. 29, 2008, pages 1976 - 1988 |
ZHANG, L. ET AL.: "Lymphatic zip codes in premalignant lesions and tumors", CANCER RES., vol. 66, 2006, pages 5696 - 5706 |
ZHANG, L.; HOFFMAN, J.A.; RUOSLAHTI, E.: "Molecular profiling of heart endothelial cells", CIRCULATION, vol. 112, 2005, pages 1601 - 1611 |
ZOLLER, CURRENT OPINION IN BIOTECHNOLOGY, vol. 3, 1992, pages 348 - 354 |
ZORKO M; LANGEL U: "Cell-penetrating peptides: mechanism and kinetics of cargo delivery", ADV DRUG DELIV REV., vol. 57, 2005, pages 529 - 45 |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016173888A1 (en) * | 2015-04-29 | 2016-11-03 | Smartgas Mikrosensorik Gmbh | Sensor for detecting the concentration of at least one medium and method for operating such a sensor |
IT201900006920A1 (en) * | 2019-05-16 | 2020-11-16 | Ft System Srl | Method and apparatus for recognizing the presence of leaks from sealed containers |
WO2020230068A1 (en) * | 2019-05-16 | 2020-11-19 | Ft System Srl | Method and apparatus for recognizing the presence of leakages from sealed containers |
CN113825992A (en) * | 2019-05-16 | 2021-12-21 | Ft系统公司 | Method and device for detecting the presence of a leak in a sealed container |
US11913662B2 (en) | 2020-10-21 | 2024-02-27 | Senseair Ab | Temperature controller for a temperature control mechanism preventing condensation |
SE544539C2 (en) * | 2020-11-18 | 2022-07-05 | Senseair Ab | Method and device for determining a concentration of a component in a fluid |
WO2022108506A1 (en) * | 2020-11-18 | 2022-05-27 | Senseair Ab | Method and device for determining a concentration of a component in a fluid |
CN116507902A (en) * | 2020-11-18 | 2023-07-28 | 森谢尔公司 | Method and apparatus for determining the concentration of a constituent in a fluid |
US11828702B2 (en) | 2020-11-18 | 2023-11-28 | Senseair Ab | Method and device for determining a concentration of a component in a fluid |
SE2051347A1 (en) * | 2020-11-18 | 2022-05-19 | Senseair Ab | Method and device for determining a concentration of a component in a fluid |
WO2023274881A1 (en) * | 2021-07-01 | 2023-01-05 | Boehringer Ingelheim Vetmedica Gmbh | Method for calibrating an optical system |
CN117470795A (en) * | 2023-12-27 | 2024-01-30 | 成都千嘉科技股份有限公司 | Non-spectroscopic infrared gas sensor and gas testing method thereof |
CN117470795B (en) * | 2023-12-27 | 2024-03-29 | 成都千嘉科技股份有限公司 | Non-spectroscopic infrared gas sensor and gas testing method thereof |
Also Published As
Publication number | Publication date |
---|---|
EP2715291A4 (en) | 2015-10-21 |
CA2837588A1 (en) | 2012-12-06 |
AU2012262488A1 (en) | 2014-01-16 |
EP2715291A2 (en) | 2014-04-09 |
WO2012166585A3 (en) | 2014-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012166585A2 (en) | Re-calibration of ab ndir gas sensors | |
US7351954B2 (en) | Method and apparatus for detecting gas concentration with infrared absorption characteristics | |
US8143581B2 (en) | Absorption biased NDIR gas sensing methodology | |
US9234905B2 (en) | Method of calibrating and calibration apparatus for a moisture concentration measurement apparatus | |
US8178832B1 (en) | Re-calibration methodology for NDIR gas sensors | |
CN107850534B (en) | Gas detection device and method | |
US8158945B2 (en) | Detector arrangement for a nondispersive infrared gas analyzer and method for the detection of a measuring gas component in a gas mixture by means of such a gas analyzer | |
EP2338042A1 (en) | Method of calibrating a wavelength-modulation spectroscopy apparatus | |
CN105765381B (en) | For the method and system for the gas concentration for measuring the gas of dissolving in a liquid | |
US8217355B1 (en) | Self-commissioning NDIR gas sensors | |
US8222606B1 (en) | Air sampler for recalibration of absorption biased designed NDIR gas sensors | |
JP2006201156A (en) | Device and method for compensating temperature dependence of detector used for spectrometer | |
CN1971247B (en) | Method for cross interference correction for correlation spectroscopy | |
CN110006836B (en) | Device and method for identifying and measuring anesthetic gas | |
US10088416B2 (en) | Method and device for determining gas component inside a transparent container | |
US11828702B2 (en) | Method and device for determining a concentration of a component in a fluid | |
Huber et al. | A selective, miniaturized, low-cost detection element for a photoacoustic CO2 sensor for room climate monitoring | |
US20140104613A1 (en) | Spectral calibration method | |
KR101571859B1 (en) | Apparatus and method of analying element concentration using atomic absorption spectrophotometry | |
JP2017032317A (en) | Gas concentration measurement device | |
Ashraf et al. | Evaluation of a CO 2 sensitive thermopile with an integrated multilayered infrared absorber by using a long path length NDIR platform | |
US20100140477A1 (en) | Method and device for gas analysis | |
Wong et al. | Recalibration technique for NDIR gas sensors without the need for gas standards | |
JP7192602B2 (en) | Calibration method for gas concentration measuring device | |
JP6571476B2 (en) | Gas concentration measuring device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12794011 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2837588 Country of ref document: CA |
|
REEP | Request for entry into the european phase |
Ref document number: 2012794011 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012794011 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2012262488 Country of ref document: AU Date of ref document: 20120525 Kind code of ref document: A |